Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.

Also called NCT06281977

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 192 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06281977
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06281977. Randomized; triple masking; primary purpose treatment. Start 2024-05-08 (actual); primary completion 2027-05-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
Acronym
SEDATE
Condition
Ventricular Tachycardia
Condition
Ventricular Arrhythmias
Condition
Recurrent Ventricular Tachycardia
Intervention (Drug)
Dexmedetomidine
Intervention (Drug)
Normal saline
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct06281977
Content hash
1c49eccbc702f37c973dae44dd83c6244d69894f4224c4627d9ae045e419c03e